1-9 of 9
J Crawford
Close
Sort by
Journal Articles

Targeting HUWE1 in Multiple Myeloma Leads to Impaired Replicative Stress Response and Enhanced Sensitivity to Bortezomib

Jonathan J Morgan, Bryony G Kennedy, Rich Williams, Ken I Mills, Lisa J Crawford
Journal: Blood
Blood (2023) 142 (Supplement 1): 2774.
https://doi.org/10.1182/blood-2023-185913
Published: 2023
Journal Articles

TRIM33 Loss in Multiple Myeloma Impairs the DNA Damage Response Resulting in Sensitivity to PARP and ATR Inhibitors

Roisin M McAvera, Jonathan J Morgan, Ken I Mills, Lisa J Crawford
Journal: Blood
Blood (2021) 138 (Supplement 1): 1570.
https://doi.org/10.1182/blood-2021-147728
Published: 2021
Journal Articles

Relationship between HUWE1 Mutation and Functionality in Multiple Myeloma

Lisa J Crawford, BSc, PhD, David Campbell, BSc, PhD, Ken I Mills, PhD FRCPath, BSc, Alexandra E Irvine, PhD FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 4512.
https://doi.org/10.1182/blood-2018-99-118294
Published: 2018
Journal Articles

HUWE1 Inhibition As a Therapeutic Strategy to Target MYC in MM

Lisa J Crawford, BSc, PhD, Dharminder Chauhan, PhD, Alexandra E Irvine, PhD FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 3077.
https://doi.org/10.1182/blood.V130.Suppl_1.3077.3077
Published: 2017
Journal Articles

DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia

Elaine Willmore, BSc, PhD, Sarah L. Elliott, Clark J. Crawford, Geoffrey Summerfield, Tryfonia Mainou-Fowler, Graham Jackson, Paul Evans, Paula Newton, Duncan Gowans, Barbara W. Durkacz
Journal: Blood
Blood (2008) 112 (11): 382.
https://doi.org/10.1182/blood.V112.11.382.382
Published: 2008
Journal Articles

The Effect of Hemoglobin (Hb) Level at ESA Initiation on Outcomes in Cancer Patients (pts) with Chemotherapy-Induced Anemia (CIA): A Patient-Based Meta-Analysis from 6 Randomized, Placebo-Controlled Trials (RCTs) of Darbepoetin alfa (DA).

J. Crawford, MD, D. Henry, MD, J. Vansteenkiste, MD, H. Ludwig, MD, T. Lillie, MD, A. Fleishman, MS, J. Glaspy, MD
Journal: Blood
Blood (2007) 110 (11): 3780.
https://doi.org/10.1182/blood.V110.11.3780.3780
Published: 2007
Journal Articles

Evaluating the Safety of Erythropoiesis-Stimulating Agents (ESAs) in Patients with Breast Cancer, Lung Cancer, and Hematologic Malignancies: A Meta-Analysis of Randomized, Controlled Trials.

J. Glaspy, MD, D. Henry, MD, J. Vansteenkiste, MD, H. Ludwig, MD, T. Lillie, MD, D. Tomita, MPH, J. Crawford, MD
Journal: Blood
Blood (2007) 110 (11): 3669.
https://doi.org/10.1182/blood.V110.11.3669.3669
Published: 2007
Journal Articles

Adiponectin Produced by Lymphocytes Inhibits Granulopoiesis.

Lisa J. Crawford, PhD, Roy W. Peake, PhD, Susan Price, BSc, Treen C. Morris, MD, Alexandra E. Irvine, PhD
Journal: Blood
Blood (2006) 108 (11): 1275.
https://doi.org/10.1182/blood.V108.11.1275.1275
Published: 2006
Journal Articles

Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders

MS Currie, M Vala, DS Pisetsky, CS Greenberg, J Crawford, HJ Cohen
Journal: Blood
Blood (1990) 75 (8): 1699–1704.
https://doi.org/10.1182/blood.V75.8.1699.1699
Published: 1990